COMPOSITION

Vectormune^® ND Rispens contains genetically engineered Mark's disease vaccine of serotype 3 (Turkey herpesvirus or HVT) expressing key protectivE antigens of Newcastle disease virus and a serotype 1 (Rispens) Marek's disease virus. The bivalenT Marek's disease vaccine containing serotypes 1 and 3 is presented in a frozen cell-associated form.

ADMINISTRATION AND DOSAGE

Prior to use, the vaccine must be thawed and diluted appropriately with the vaccine diluent as stated in the package insert. Immediately use the vaccine and mix occasionally to ensure uniform suspension of cells.

For in-ovo administration:

Embyros are inoculated with one full dose of vaccine (0.05 mL)

For day-old chicks:

Day-old chicks are subcutaneously vaccinated with 0.2 mL of vaccine in the back of the neck.

STORAGE

Store this vaccine in dewars containing liquid nitrogen.

PACKAGING

1000, 2000 and 4000 dose ampules

FOR ANIMAL TREATMENT ONLY